Analyst Ratings For Nightstar Therapeutics (NASDAQ:NITE)
Today, Wedbush raised its price target on Nightstar Therapeutics (NASDAQ:NITE) to $31.00 per share.
Some recent analyst ratings include
- 1/3/2018-Chardan Capital initiated coverage with a Buy rating.
- 10/23/2017-Leerink Swann initiated coverage with a Outperform rating.
- 10/23/2017-Jefferies Group initiated coverage with a Buy rating.
- 10/23/2017-BMO Capital Markets initiated coverage with a Outperform rating.
Recent Trading Activity for Nightstar Therapeutics (NASDAQ:NITE)
Shares of Nightstar Therapeutics closed the previous trading session at 14.70 down -0.05 0.34% with 14.369999885559082 shares trading hands.